STGD1 clinical trials at UCSF
1 research study open to eligible people
Showing trials for
Tinlarebant in Subjects With Stargardt Disease
open to eligible people ages 12-20
The goal of this clinical trial is to evaluate the safety, tolerability, and efficacy of tinlarebant in subjects with Stargardt Disease
San Francisco 5391959, California 5332921 and other locations
Last updated: